Live-cell imaging of caspase activation for high-content screening

Journal of Biomolecular Screening

Volumn 14, Issue 8, 2009, Pages 956-969

  Antczak, Christophe ^a   Takagi, Toshimitsu ^a   Ramirez, Christina N ^a   Radu, Constantin ^a   Djaballah, Hakim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; Cancer; Caspase; Chemical HT screening; High content assay; Live cells; RNAi HT screening

Indexed keywords

ASPARTYLGLUTAMYLVALYL ASPARTIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; PEPTIDE; PROTEIN BCL XL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FEMALE; GENE LIBRARY; GENE OVEREXPRESSION; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR IMAGING; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; DIAGNOSTIC IMAGING; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MODELS, BIOLOGICAL; TRANSFECTION;

EID: 70349650786     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057109343207     Document Type: Article

References (25)

1. Hanahan D., Weinberg RA: The hallmarks of cancer. Cell 2000 ; 100: 57-70.
2. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972 ; 26: 239-257.
3. Naqvi T., Lim A., Rouhani R., Singh R., Eglen RM: Beta galactosidase enzyme fragment complementation as a high-throughput screening protease technology. J Biomol Screen 2004 ; 9: 398-408.
4. Eymin B., Leduc C., Coll JL, Brambilla E., Gazzeri S.: p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003 ; 22: 1822-1835.
5. Tucker B., Lardelli M.: A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos. Zebrafish 2007 ; 4: 113-116.
6. Gilmore K., Wilson M.: The use of chloromethyl-X-rosamine (Mitotracker red) to measure loss of mitochondrial membrane potential in apoptotic cells is incompatible with cell fixation. Cytometry 1999 ; 36: 355-358.
7. MacKeigan JP, Murphy LO, Blenis J.: Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 2005 ; 7: 591-600.
8. Hagg M., Biven K., Ueno T., Rydlander L., Bjorklund P., Wiman KG, et al. A novel high-through-put assay for screening of pro-apoptotic drugs. Invest New Drugs 2002 ; 20: 253-259.
9. Fennell M., Chan H., Wood A.: Multiparameter measurement of caspase 3 activation and apoptotic cell death in NT2 neuronal precursor cells using high-content analysis. J Biomol Screen 2006 ; 11: 296-302.
10. Bedner E., Smolewski P., Amstad P., Darzynkiewicz Z.: Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res 2000 ; 259: 308-313.
11. Fan F., Wood KV: Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 2007 ; 5: 127-136.
12. Yu K., Kennedy CA, Oĝ€™Neill MM, Barton RW, Tatake RJ: Disparate cleavage of poly-(ADP-ribose)-polymerase (PARP) and a synthetic tetrapeptide, DEVD, by apoptotic cells. Apoptosis 2001 ; 6: 151-160.
13. Tawa P., Tam J., Cassady R., Nicholson DW, Xanthoudakis S.: Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ 2001 ; 8: 30-37.
14. Coppola JM, Ross BD, Rehemtulla A.: Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res 2008 ; 14: 2492-2501.
15. Cen H., Mao F., Aronchik I., Fuentes RJ, Firestone GL: DEVD-NucView488: a novel class of enzyme substrates for real-time detection of caspase-3 activity in live cells. FASEB J 2008 ; 22: 2243-2252.
16. Shan P., Pu J., Yuan A., Shen L., Chai D., He B.: RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochem Biophys Res Commun 2008 ; 375: 628-633.
17. Jones S., Martel C., Belzacq-Casagrande AS, Brenner C., Howl J.: Mitoparan and target-selective chimeric analogues: membrane translocation and intracellular redistribution induces mitochondrial apoptosis. Biochim Biophys Acta 2008 ; 1783: 849-863.
18. Zhu QS, Ren W., Korchin B., Lahat G., Dicker A., Lu Y., et al. Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha. Cancer Res 2008 ; 68: 2895-2903.
19. Nijhawan D., Fang M., Traer E., Zhong Q., Gao W., Du F., et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003 ; 17: 1475-1486.
20. Shao RG, Cao CX, Pommier Y.: Activation of PKCalpha downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells. J Biol Chem 1997 ; 272: 31321-31325.
21. Pao W., Miller VA, Politi KA, Riely GJ, Somwar R., Zakowski MF, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005 ; 2: e73.
22. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T., Garcia-Calvo M., et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J Biol Chem 1997 ; 272: 17907-17911.
23. Gabelica V., Rosu F., De Pauw E., Antoine R., Tabarin T., Broyer M., et al. Electron photodetachment dissociation of DNA anions with covalently or noncovalently bound chromophores. J Am Soc Mass Spectrom 2007 ; 18: 1990-2000.
24. Krishan A.: Flow cytometric studies on intracellular drug fluorescence. In Darzynkiewicz JWGaZ (ed): Techniques in Cell Cycle Analysis. Totowa, NJ: Humana, 1987: 337-366.
25. Preisler HD: Alteration of binding of the supravital dye Hoechst 33342 to human leukemic cells by adriamycin. Cancer Treat Rep 1978 ; 62: 1393-1396.